Literature DB >> 12695356

Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption.

Jean-Paul Payan1, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari, Jean-Claude André.   

Abstract

Neat N-methyl-2-pyrrolidone (NMP) rapidly penetrated into the skin of male Sprague-Dawley rats after in vivo and in vitro topical application. At the two topical doses tested in vivo, no steady state was observed. The maximal absorption fluxes were 10 and 20 mg/cm(2)/h for 20 microl/cm(2) and 40 microl/cm(2), respectively. Similar results were observed after in vitro topical application of neat [(14)C]NMP (25-400 microl/cm(2)) in fresh full-thickness skin. Whatever the dose tested, the percutaneous absorption fluxes increased with exposure time to reach a maximum value (F(max)) and then decreased. F(max) and the time to reach it (T(max)) increased as the dose increased. At the highest dose, which may be considered as an "infinite dose," the maximal flux (7.7 +/- 1.1 mg/cm(2)/h, n = 12) occurred 6 h after the topical application of NMP. The decrease on percutaneous absorption flux was correlated with the dilution of neat NMP with water from the receptor fluid. A semi-quantitative mathematical model was developed to describe the absorption flux of NMP taking into account the transfer of water through the skin. The K(p) values determined from the different aqueous solutions of NMP (1:1 to 1:32, v/v) were not significantly different. The mean value was 6.4 (10(-3) cm/h) (range, 4.7 to 7.6). Occlusion did not affect the percutaneous absorption flux of neat NMP. Desquamation increased the percutaneous absorption of NMP slightly. The skin did not metabolize NMP. The flux was dependent on the thickness of the skin and was proportional to the concentration of NMP. These findings suggest a passive diffusion of NMP through the skin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695356     DOI: 10.1124/dmd.31.5.659

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  4 in total

1.  Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone.

Authors:  Michael Bader; Stephen A Keener; Renate Wrbitzky
Journal:  Int Arch Occup Environ Health       Date:  2005-10-12       Impact factor: 3.015

2.  Organic solvents as vehicles for precipitating liquid embolics: a comparative angiotoxicity study with superselective injections of swine rete mirabile.

Authors:  O Dudeck; O Jordan; K T Hoffmann; A F Okuducu; K Tesmer; T Kreuzer-Nagy; D A Rüfenacht; E Doelker; R Felix
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

3.  Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway.

Authors:  Koji Yamaguchi; Tetsuya Mitsui; Toshinori Yamamoto; Rie Shiokawa; Yuko Nomiyama; Norihisa Ohishi; Yoshinori Aso; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2006-03-25       Impact factor: 4.200

4.  Toxicological screening.

Authors:  S Parasuraman
Journal:  J Pharmacol Pharmacother       Date:  2011-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.